Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34357781

E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Oct 1
First author
Connolly RM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Thorac Cancer. 2022 May;13(9):1237-1239. doi: 10.1111/1759-7714.14399.
    note
    Source null
    related pmid
    35352486
    relationship
    Comment in

Authors and identifiers

  1. name
    Connolly RM
    type
    Author
  2. name
    Zhao F
    type
    Author
  3. name
    Miller KD
    type
    Author
  4. name
    Lee MJ
    type
    Author
  5. name
    Piekarz RL
    type
    Author
  6. name
    Smith KL
    type
    Author
  7. name
    Brown-Glaberman UA
    type
    Author
  8. name
    Winn JS
    type
    Author
  9. name
    Faller BA
    type
    Author
  10. name
    Onitilo AA
    type
    Author
  11. name
    Burkard ME
    type
    Author
  12. name
    Budd GT
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Connolly RM
    type
    Author
  2. name
    Zhao F
    type
    Author
  3. name
    Miller KD
    type
    Author
  4. name
    Lee MJ
    type
    Author
  5. name
    Piekarz RL
    type
    Author
  6. name
    Smith KL
    type
    Author
  7. name
    Brown-Glaberman UA
    type
    Author
  8. name
    Winn JS
    type
    Author
  9. name
    Faller BA
    type
    Author
  10. name
    Onitilo AA
    type
    Author
  11. name
    Burkard ME
    type
    Author
  12. name
    Budd GT
    type
    Author
bibliography ids
  1. nci-bib-0637c4a649c1120ffd4f0247
book metadata
content sha256
bb7edbc12776b3452e1e1e89fcd292bcdacaa0bff61786a992a5a7c7117c9e63
document type
citation
dois
  1. 10.1200/JCO.21.00944
electronic publication date
display
2021 Aug 6
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34357781
immutable id
pubmed:34357781@bb7edbc12776b3452e1e1e89fcd292bcdacaa0bff61786a992a5a7c7117c9e63
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
28
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3171-3181
volume
39
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Thorac Cancer. 2022 May;13(9):1237-1239. doi: 10.1111/1759-7714.14399.
    note
    Source null
    related pmid
    35352486
    relationship
    Comment in
outcomes validated
false
pmid
34357781
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
278ccb3d48ed51594c1cdd06123d4b120ae93473d5658375430d973c47aefa3c
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Oct 1
precision
day
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34357781/
title
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group.

Preserved source evidence · Not medical advice